Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-01-04 @ 8:40 AM
Study NCT ID:
NCT00114959
Status:
TERMINATED
Last Update Posted:
2015-01-15
First Post:
2005-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Sponsor:
ChemGenex Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-20
First Submit QC Date:
None
Study First Post Date:
2005-06-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-08
Results First Submit QC Date:
None
Results First Post Date:
2015-01-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-05-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-01-08
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED